January 29, 2025 10:10 AM EST
News Briefing

Curie.Bio has a new $340M fund; Lay­offs at Bench­ling, I-Mab

ENDPOINTS

Plus, news about Cul­li­nan Ther­a­peu­tics, Reg­u­lus and Im­vax:

Curie.Bio’s new $340M fund: The in­vest­ment firm and biotech start­up in­cu­ba­tor dis­closed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

Car­go Ther­a­peu­tics cuts lead CAR-T pro­gram, 50% of staff

Take­da scraps pro­grams as it rais­es full-year guid­ance 

Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

Sanofi is in the mar­ket for M&A, thanks to ‘strong’ bal­ance sheet

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times